Sector Expert: Brian Bloom

Bloom Burton & Co.

Image: Brian  Bloom

Brian Bloom is a cofounder of Bloom Burton & Co. and serves as the firm's president and head of institutional sales and capital market activities. By forging unique relationships with international healthcare-specialized investors, Bloom attracts capital for growing companies seeking to accelerate returns for investors. Before co-founding Bloom Burton, Bloom spent six years at Dundee Securities in the healthcare and biotechnology institutional sales and equity research groups. Earlier in his career, he spent two years in the equity research group at a New York-based merchant banking firm, SCO Group, and was an investment banking analyst at M&A advisory firm, Molecular Securities. Bloom is a member of the Life Sciences Advisory Board at the National Research Council of Canada and the Board of Directors at BIOTECanada. Bloom received an bachelor's degree with honors in biochemistry from McMaster University and subsequently studied at the Mount Sinai Graduate School for Biological Sciences of New York University with a focus in molecular endocrinology and biophysics.



Recent Quotes

"We believe BLU has a higher probability of success in its current Phase 3 Kiacta study."

The Life Sciences Report interview with Brian Bloom (6/12/14)
more >

"TRX is my favorite specialty pharmaceutical company right now, based on its valuation."

The Life Sciences Report interview with Brian Bloom (6/12/14)
more >



Due to permission requirements, not all quotes are shown.